Compare COTY & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COTY | BIRK |
|---|---|---|
| Founded | 1904 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 6.1B |
| IPO Year | 2012 | 2023 |
| Metric | COTY | BIRK |
|---|---|---|
| Price | $2.16 | $35.23 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 17 | 14 |
| Target Price | $4.46 | ★ $62.69 |
| AVG Volume (30 Days) | ★ 6.1M | 2.2M |
| Earning Date | 05-05-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,892,900,000.00 | N/A |
| Revenue This Year | $0.19 | $13.71 |
| Revenue Next Year | $1.44 | $14.21 |
| P/E Ratio | ★ N/A | $17.48 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.09 | $33.06 |
| 52 Week High | $5.70 | $57.39 |
| Indicator | COTY | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 27.76 | 39.48 |
| Support Level | N/A | N/A |
| Resistance Level | $3.43 | $42.19 |
| Average True Range (ATR) | 0.08 | 1.48 |
| MACD | -0.00 | -0.44 |
| Stochastic Oscillator | 13.75 | 24.52 |
Coty is a global beauty maker that generates 65% of sales from prestige beauty products (primarily fragrances) and 35% from mass makeup, skin care, and fragrance. For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein. In contrast, its consumer cosmetics business focuses on acquired mass brands such as CoverGirl, Max Factor, Rimmel, Sally Hansen, and Bourjois. It also collaborates with social media celebrity Kylie Jenner to manage makeup products bearing her name. By region, Coty generates close to 48% of sales from Europe, 40% from the Americas, and 12% from Asia-Pacific. German investment firm JAB is a controlling shareholder, with a 54% stake.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.